New drug treats age-related macular degeneration.
D052157:Aptamers, Nucleotide; D017277:Drug Approval; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D009841:Oligonucleotides / Q000627:therapeutic use*
D052157:Aptamers, Nucleotide; D009841:Oligonucleotides; C495058:pegaptanib